Deka-Duralin 100 AMPULES - Pharmaceutical Grade

Nandrolone decanoate, launched as Deca-Durabolin in 1962, became a preferred agent in treating a variety of chronic medical conditions. It was indicated for osteoporosis, severe trauma, anemia, and growth disorders, including pediatric dwarfism. The ester decanoate slowed its release significantly, allowing for injections every two to four weeks. By the mid-1970s, approved uses narrowed, but its favorable safety profile and long-acting properties kept it active globally, with Merck/MSD now managing distribution in limited human and veterinary markets​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Deka-Duralin 100 AMPULES by Pharmaceutical Grade, consult with your doctor or healthcare professional.